Arcus Biosciences Ownership | Who Owns Arcus Biosciences?
Arcus Biosciences Ownership Summary
Arcus Biosciences is owned by 58.26% institutional investors, 40.60% insiders, and 1.14% retail investors. Blackrock is the largest institutional shareholder, holding 11.33% of RCUS shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 3.81% of its assets in Arcus Biosciences shares.
RCUS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Arcus Biosciences | 58.26% | 40.60% | 1.14% |
| Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
| Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 9.76M | 11.33% | $148.69M |
| Vanguard group | 5.26M | 6.10% | $80.07M |
| Woodline partners lp | 4.25M | 4.92% | $64.65M |
| Fmr | 4.18M | 4.85% | $63.67M |
| State street | 3.06M | 3.54% | $46.53M |
| Point72 asset management | 1.83M | 2.13% | $27.93M |
| Invus financial advisors | 1.61M | 1.87% | $24.55M |
| Boxer capital | 1.60M | 1.86% | $24.40M |
| Dimensional fund advisors lp | 1.48M | 1.72% | $22.53M |
| Ameriprise financial | 1.47M | 1.71% | $22.46M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Invus financial advisors | 1.61M | 27.51% | $24.55M |
| Decheng capital | 869.79K | 4.06% | $13.25M |
| Boxer capital | 1.60M | 1.28% | $24.40M |
| Dafna capital management | 253.22K | 0.92% | $3.86M |
| Parkman healthcare partners | 415.54K | 0.85% | $6.33M |
| Woodline partners lp | 4.25M | 0.62% | $64.65M |
| Suvretta capital management | 957.30K | 0.54% | $14.58M |
| Sectoral asset management | 78.39K | 0.49% | $1.19M |
| Ikarian capital | 145.00K | 0.38% | $2.21M |
| Granahan investment management | 379.85K | 0.23% | $5.79M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Woodline partners lp | 4.25M | 0.62% | 1.36M |
| Vanguard group | 5.26M | 0.00% | 466.08K |
| Goldman sachs group | 636.77K | 0.00% | 386.46K |
| Ameriprise financial | 1.47M | 0.01% | 273.42K |
| Trexquant investment lp | 252.59K | 0.06% | 214.47K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| State street | 3.06M | 0.00% | -1.85M |
| Fmr | 4.18M | 0.00% | -598.48K |
| Morgan stanley | 445.88K | 0.00% | -429.00K |
| Ubs asset management americas | 96.85K | 0.00% | -281.21K |
| Citigroup | 47.65K | 0.00% | -268.47K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Ikarian capital | 145.00K | 0.38% | 145.00K | $2.21M |
| Cubist systematic strategies | 84.46K | 0.01% | 84.46K | $1.29M |
| Boothbay fund management | 44.53K | 0.02% | 44.53K | $678.18K |
| Xtx topco | 38.76K | 0.05% | 38.76K | $590.33K |
| Corebridge financial | 31.55K | 0.00% | 31.55K | $480.48K |
Sold Out
| Holder | Change |
|---|---|
| Dinuzzo private wealth | -1.00 |
| Sjs investment consulting | -5.00 |
| Mendota financial group | -7.00 |
| Nelson, van denburg & campbell wealth management group | -10.00 |
| Abound wealth management | -13.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 190 | -4.52% | 53,251,839 | 2.50% | 58 | 1.79% | 89 | -16.82% | 70 | 16.67% |
| Jun 30, 2024 | 196 | 8.89% | 51,943,543 | -1.54% | 60 | 1.19% | 106 | 27.71% | 59 | 5.36% |
| Mar 31, 2024 | 180 | -8.16% | 52,758,521 | -0.09% | 71 | 1.42% | 83 | -5.68% | 56 | -17.65% |
| Dec 31, 2023 | 196 | -1.51% | 52,803,736 | 0.14% | 70 | 1.36% | 88 | 8.64% | 68 | -8.11% |
| Sep 30, 2023 | 199 | 3.65% | 52,731,288 | -3.60% | 72 | 1.28% | 81 | -2.41% | 74 | 12.12% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 3.49M | 3.81% | 1.79K |
| Fidelity Select Biotechnology | 1.88M | 2.05% | -124.60K |
| Vanguard Total Stock Mkt Idx Inv | 1.58M | 1.73% | - |
| iShares Russell 2000 ETF | 1.45M | 1.59% | -5.58K |
| SPDR® S&P Biotech ETF | 884.87K | 0.97% | -10.33K |
| Vanguard Institutional Extnd Mkt Idx Tr | 813.68K | 0.89% | -26.56K |
| Fidelity Select Pharmaceuticals Port | 760.00K | 0.83% | -89.80K |
| BNP Paribas Health Cr Innovtr Cl Cap | 727.44K | 0.79% | 9.90K |
| BNP Paribas US Small Cap Classic R | 700.51K | 0.77% | 155.22K |
| Fidelity Select Health Care | 700.00K | 0.76% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 31, 2024 | Goeltz II Robert C. | Chief Financial Officer | Sell | $53.91K |
| Dec 02, 2024 | Azoy Alexander | Chief Accounting Officer | Sell | $3.08K |
| Aug 13, 2024 | Azoy Alexander | Chief Accounting Officer | Sell | $20.31K |
| Mar 27, 2024 | Jarrett Jennifer | Chief Operating Officer | Sell | $202.72K |
| Mar 18, 2024 | Jarrett Jennifer | Chief Operating Officer | Sell | $24.13K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | 1 |
| 2024 Q3 | - | 1 |
| 2024 Q2 | - | - |
| 2024 Q1 | 1 | 9 |
| 2023 Q4 | - | 2 |
RCUS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools